Comparison between tumour metabolism derived from F-FDG PET/CT and accurate cytogenetic stratification in newly diagnosed multiple myeloma patients.

Fiche publication


Date publication

octobre 2021

Journal

Quantitative imaging in medicine and surgery

Auteurs

Membres identifiés du Cancéropôle Est :
Dr CAILLOT Denis, Pr COCHET Alexandre, Pr LOFFROY Romaric, Dr CHRETIEN Marie-Lorraine


Tous les auteurs :
Silva Y, Riedinger JM, Chrétien ML, Caillot D, Corre J, Guillen K, Cochet A, Tabouret-Viaud C, Loffroy R

Résumé

F-fluorodeoxyglucose positron emission tomography integrated with computed tomography (F-FDG PET/CT) is a useful tool for baseline staging in newly diagnosed multiple myeloma (MM) but also for prognostic stratification. This monocentric retrospective study aimed at examining the relation between baseline tumour metabolism assessed by F-FDG PET/CT and linear predictor (LP) score, a new cytogenetic stratification score.

Mots clés

18F-fluorodeoxyglucose positron emission tomography integrated with computed tomography (18F-FDG PET/CT), Multiple myeloma (MM), cytogenetic stratification, linear predictor score (LP score), metabolic volume

Référence

Quant Imaging Med Surg. 2021 Oct;11(10):4299-4309